Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10
Elizabeth Evans, Libo Li, Jeong Eun Min, et al.
Addiction (2015) Vol. 110, Iss. 6, pp. 996-1005
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo, Gregorio Barrio, María J. Bravo, et al.
BMJ (2017), pp. j1550-j1550
Open Access | Times Cited: 1453
Treatment of Opioid-Use Disorders
Marc A. Schuckit
New England Journal of Medicine (2016) Vol. 375, Iss. 4, pp. 357-368
Open Access | Times Cited: 468
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Thomas Santo, Brodie Clark, Matthew Hickman, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 9, pp. 979-979
Open Access | Times Cited: 366
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis
Jun Ma, Yanping Bao, Rujia Wang, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 12, pp. 1868-1883
Closed Access | Times Cited: 316
Retention of patients in opioid substitution treatment: A systematic review
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232086-e0232086
Open Access | Times Cited: 218
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
Rebecca L. Haffajee, Amy S. B. Bohnert, Pooja Lagisetty
American Journal of Preventive Medicine (2018) Vol. 54, Iss. 6, pp. S230-S242
Open Access | Times Cited: 209
The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting
Joseph K. Eibl, Graham Gauthier, David Pellegrini, et al.
Drug and Alcohol Dependence (2017) Vol. 176, pp. 133-138
Open Access | Times Cited: 173
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study
Lindsay A Pearce, Jeong Eun Min, Micah Piske, et al.
BMJ (2020), pp. m772-m772
Open Access | Times Cited: 147
Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services
Noa Krawczyk, Ramin Mojtabai, Elizabeth A. Stuart, et al.
Addiction (2020) Vol. 115, Iss. 9, pp. 1683-1694
Open Access | Times Cited: 140
Cost-effectiveness of Treatments for Opioid Use Disorder
Michael Fairley, Keith Humphreys, Vilija R. Joyce, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 7, pp. 767-767
Open Access | Times Cited: 107
High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System
Yih‐Ing Hser, Larissa J. Mooney, Andrew J. Saxon, et al.
Journal of Addiction Medicine (2017) Vol. 11, Iss. 4, pp. 315-319
Open Access | Times Cited: 160
Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel
Lynn Kohan, Sudheer Potru, Antje M. Barreveld, et al.
Regional Anesthesia & Pain Medicine (2021) Vol. 46, Iss. 10, pp. 840-859
Open Access | Times Cited: 94
Trends in Opioid Use Disorder Among Older Adults: Analyzing Medicare Data, 2013–2018
Carla Shoff, Tse‐Chuan Yang, Benjamín A. Shaw
American Journal of Preventive Medicine (2021) Vol. 60, Iss. 6, pp. 850-855
Open Access | Times Cited: 64
High levels of all-cause mortality among people who inject drugs from 2018 to 2022
Sotirios Roussos, Theodoros Angelopoulos, Εvangelos Cholongitas, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104356-104356
Closed Access | Times Cited: 8
The societal cost of heroin use disorder in the United States
Ruixuan Jiang, In-Young Lee, Todd A. Lee, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0177323-e0177323
Open Access | Times Cited: 64
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
Tyler S. Bartholomew, Barbara Andraka-Cristou, Rachel Totaram, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Patient Acceptance of Emergency Department-Initiated Buprenorphine and Reasons for Declining
Lindsey Jennings, Allison Smith, Angela D. Moreland, et al.
JEM Reports (2025), pp. 100141-100141
Open Access
The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting
Seonaid Nolan, Kanna Hayashi, M‐J Milloy, et al.
Drug and Alcohol Dependence (2015) Vol. 156, pp. 57-61
Open Access | Times Cited: 60
Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample
Michael Soyka, Jens Strehle, Jürgen Rehm, et al.
European Addiction Research (2017) Vol. 23, Iss. 2, pp. 97-105
Open Access | Times Cited: 54
A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences
Davida M. Schiff, Mari‐Lynn Drainoni, Zoe Weinstein, et al.
Journal of Substance Abuse Treatment (2017) Vol. 82, pp. 41-47
Closed Access | Times Cited: 49
Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
Emanuel Krebs, Benjamin Enns, Elizabeth Evans, et al.
Annals of Internal Medicine (2017) Vol. 168, Iss. 1, pp. 10-10
Closed Access | Times Cited: 49
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care
Abriana Tasillo, Golnaz Eftekhari Yazdi, Shayla Nolen, et al.
Obstetrics and Gynecology (2019) Vol. 133, Iss. 2, pp. 289-300
Open Access | Times Cited: 47
Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic
Stephanie Ann Hooker, Michelle D. Sherman, Mary E. Lonergan, et al.
Journal of Primary Care & Community Health (2020) Vol. 11
Open Access | Times Cited: 44
Association between mortality rates and medication and residential treatment after in‐patient medically managed opioid withdrawal: a cohort analysis
Alexander Y. Walley, Sara Lodi, Yijing Li, et al.
Addiction (2020) Vol. 115, Iss. 8, pp. 1496-1508
Open Access | Times Cited: 42
Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems
Denise M. Boudreau, Gwen T. Lapham, Eric A. Johnson, et al.
Journal of Substance Abuse Treatment (2020) Vol. 112, pp. 41-48
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top